Sign In
Buy QTRX
$3.22
-0.270 (-7.74%)
At Close: Jun 23, 2026
Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024
04:01pm, Tuesday, 12'th Nov 2024
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced preliminary financial resul
Quanterix To Report Third Quarter 2024 Financial Results on November 12, 2024
04:00pm, Tuesday, 05'th Nov 2024
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conferen
BILLERICA, Mass.--(BUSINESS WIRE)--Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), has introduced LucentAD Complete, a new multi-marker blood test designed to help detect Alzheime
Quanterix Welcomes Ivana Magovčević-Liebisch, Ph.D., J.D. to Board of Directors
04:00pm, Wednesday, 02'nd Oct 2024
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced
Quanterix Announces Commercialization of p-Tau 217 Test Kit
04:00pm, Monday, 30'th Sep 2024
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced
Quanterix Corporation: Still Struggling To Gain Traction
09:27am, Monday, 26'th Aug 2024
Today, we revisit Quanterix Corporation, which provides ultra-sensitive digital assay platforms for detecting protein biomarkers in healthcare. The company has a pristine balance sheet with some $300
Jeffrey Elliott Appointed to Quanterix's Board of Directors
04:32pm, Monday, 19'th Aug 2024
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultra-sensitive biomarker detection, today announce
Quanterix Corporation (QTRX) Reports Q2 Loss, Tops Revenue Estimates
06:11pm, Thursday, 08'th Aug 2024
Quanterix Corporation (QTRX) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.16 per share a year ago.
Analysts Estimate Quanterix Corporation (QTRX) to Report a Decline in Earnings: What to Look Out for
11:06am, Monday, 29'th Jul 2024
Quanterix (QTRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quanterix to Participate at the Scotiabank Healthcare 1x1 Day
04:00pm, Monday, 17'th Jun 2024
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer
Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference
04:00pm, Wednesday, 05'th Jun 2024
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer
Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024
04:00pm, Wednesday, 22'nd May 2024
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer
Wall Street Analysts Believe Quanterix (QTRX) Could Rally 67.66%: Here's is How to Trade
10:56am, Wednesday, 15'th May 2024
The consensus price target hints at a 67.7% upside potential for Quanterix (QTRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimat
Quanterix Corporation (QTRX) Q1 2024 Earnings Call Transcript
02:40pm, Wednesday, 08'th May 2024
Quanterix Corporation (NASDAQ:QTRX ) Q1 2024 Earnings Conference Call May 8, 2024 8:30 AM ET Company Participants Francis Pruell - Investor Relations Masoud Toloue - President and Chief Executive Offi
Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates
06:11pm, Tuesday, 07'th May 2024
Quanterix Corporation (QTRX) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.16 per share a year ago.
